Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:33 pm Sale |
2024-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
EcoR1 Capital LLC | 10,630,736 9.900% |
-2,700,000 (-20.25%) |
Filing History |
| 2025-01-02 07:07 am Sale |
2024-12-30 | 13D | Tango Therapeutics, Inc. TNGX |
BCTG Holdings, LLC | 10,740,385 10.000% |
-4,473,668 (-29.40%) |
Filing History |
| 2024-12-06 11:14 am Sale |
2024-11-29 | 13G | Tango Therapeutics, Inc. TNGX |
FMR CORP | 13,392 0.000% |
-9,773,958 (-99.86%) |
Filing History |
| 2024-11-20 4:24 pm Purchase |
2024-11-13 | 13G | Tango Therapeutics, Inc. TNGX |
TCG Crossover GP II, LLC | 10,500,612 9.800% |
10,500,612 (New Position) |
Filing History |
| 2024-11-07 9:35 pm Unchanged |
2024-11-06 | 13D | Tango Therapeutics, Inc. TNGX |
Boxer Capital Management LLC | 6,988,450 6.500% |
0 (Unchanged) |
Filing History |
| 2024-10-28 09:22 am Purchase |
2024-10-25 | 13D | Tango Therapeutics, Inc. TNGX |
Boxer Capital Management LLC | 6,988,450 6.500% |
6,988,450 (New Position) |
Filing History |
| 2024-10-15 9:40 pm Purchase |
2024-10-10 | 13D | Tango Therapeutics, Inc. TNGX |
Boxer Capital LLC | 8,339,935 7.800% |
8,339,935 (New Position) |
Filing History |
| 2024-10-15 7:25 pm Purchase |
2024-10-10 | 13D | Tango Therapeutics, Inc. TNGX |
Boxer Asset Management Inc. | 26,961 0.100% |
26,961 (New Position) |
Filing History |
| 2024-09-04 8:45 pm Sale |
2024-08-30 | 13D | Tango Therapeutics, Inc. TNGX |
Third Rock Ventures IV L.P. | 17,001,475 15.900% |
-2,362,500 (-12.20%) |
Filing History |
| 2024-04-08 08:46 am Unchanged |
2024-04-08 | 13G | Tango Therapeutics, Inc. TNGX |
Southpoint Master Fund, LP | 5,276,699 4.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
Southpoint Master Fund, LP | 5,276,699 5.200% |
776,699 (+17.26%) |
Filing History |
| 2024-02-13 4:51 pm Unchanged |
2023-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
GILEAD SCIENCES INC GILD |
4,854,443 4.800% |
0 (Unchanged) |
Filing History |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | Tango Therapeutics, Inc. TNGX |
FMR CORP | 9,787,350 9.596% |
-3,760,722 (-27.76%) |
Filing History |
| 2023-10-18 5:23 pm Purchase |
2023-10-16 | 13D | Tango Therapeutics, Inc. TNGX |
BCTG Holdings, LLC | 15,214,053 15.000% |
1,075,000 (+7.60%) |
Filing History |
| 2023-10-16 3:33 pm Purchase |
2023-10-13 | 13G | Tango Therapeutics, Inc. TNGX |
EcoR1 Capital LLC | 13,330,736 13.100% |
5,503,100 (+70.30%) |
Filing History |
| 2023-09-21 5:16 pm Purchase |
2023-09-11 | 13G | Tango Therapeutics, Inc. TNGX |
EcoR1 Capital LLC | 7,827,636 7.700% |
7,827,636 (New Position) |
Filing History |
| 2023-09-11 08:23 am Purchase |
2023-09-08 | 13G | Tango Therapeutics, Inc. TNGX |
FMR CORP | 13,548,072 13.326% |
4,464,393 (+49.15%) |
Filing History |
| 2023-08-21 4:16 pm Purchase |
2023-08-11 | 13G | Tango Therapeutics, Inc. TNGX |
Nextech Crossover I GP S.a r.l. | 5,533,980 5.400% |
5,533,980 (New Position) |
Filing History |
| 2023-08-16 4:40 pm Purchase |
2023-08-11 | 13D | Tango Therapeutics, Inc. TNGX |
BCTG Holdings, LLC | 14,139,053 13.900% |
7,150,603 (+102.32%) |
Filing History |
| 2023-02-14 3:02 pm Sale |
2022-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
Cormorant Asset Management LP | 4,116,949 4.670% |
-782,235 (-15.97%) |
Filing History |